Inside the dark caverns of the human body, a war is on. Nano-sized, silent and invisible to the naked eye, but brutal and singularly cunning. A viral predator is planning to storm the body’s citadels: the cells. Covert operations are underway.
The virus is undulating its spikes, like balloons on a string. Each spike is coated with sugar the primordial molecule to trick the cells into believing what’s landing is safe.
The camouflage works: cells pop open. Even the powerful soldiers of the body’s immune system miss the malignant presence.
With the potent protein of its spikes, the virus breaks in, to hijack, plunder and infect the cells. In a matter of hours, virus particles appear in every teaspoon of the victim’s blood. An ancient warfare between mankind and pathogens, that has turned a new page in modern times.
Scientists Urge Govt to Release Covaxin Phase 3 Trial Data Before Rollout 15/01/2021
A health worker holds a vial of the Covishield vaccine candidate, after it arrived at a hospital in Ahmedabad, January 12, 2021. Photo: PTI.
New Delhi: After the Union health ministry released a statement by 49 doctors and scientists endorsing the safety of the Covishield and Covaxin vaccine candidates, 13 scientists issued an independent statement urging the government and Bharat Biotech to release data from phase 3 clinical trials of Covaxin, ahead of distributing it to frontline workers in the first phase of India’s vaccination drive, set to begin on January 16.
According to
Coronavirus | Indian scientists divided over nod for Covaxin
Updated:
Updated:
While some say safety parameters are good, others have asked for efficacy data
Share Article
AAA
Medical staff busy in last minute revision for vaccination at jumbo COVID-19 vaccination centre at Bandra-Kurla complex in Mumbai on the eve of first phase vaccination drive. | Photo Credit: Vivek Bendre
While some say safety parameters are good, others have asked for efficacy data
While 3,000 sites across India prepare to vaccinate three crore high-risk individuals, beginning with healthcare workers, from January 16, scientists and doctors are divided on the issue of restricted use approval granted to the Hyderabad-based Bharat Biotech’s Covaxin, a COVID-19 vaccine.
»New Strain Circulating in Britain Since Sept, Constant Tracing Must: Experts Caution as UK Flights Resume
3-MIN READ
New Strain Circulating in Britain Since Sept, Constant Tracing Must: Experts Caution as UK Flights Resume
Workers in personal protective equipment guide passengers arriving from United Kingdom on December 22, 2020. (AP Photo/Rafiq Maqbool)
According to the WHO, retrospective analysis traced the first identified variant to Kent, South East England, on 20 September 2020, which was followed by a rapid increase of the same variant identified later in November.
FOLLOW US ON:
As India gears up for mass inoculation against Covid-19 and cases of Coronavirus infection continue to see a steady trend of decline, flight services from the United Kingdom to India resumed on Friday after restrictions imposed in the wake of the new variant of Coronavirus were lifted.
73 detected to have new UK Covid mutant strain: Health Ministry
All these persons have been kept in single room isolation in designated health care facilities by respective state governments.
Share
Updated: Jan 6, 2021, 06:11 PM IST
The Central government on Wednesday said that a total of 73 persons have been detected with the new more transmissible UK coronavirus mutant strain, and they are being kept in physical isolation in health facilities.
Out of these total cases, eight have been detected by the National Centre for Disease Control (NCDC) in Delhi, 20 at the CSIR Institute of Genomics and Integrative Biology (IGIB) in Delhi, and 11 at the National Institute of Mental Health and Neuro-Sciences (NIMHANS) in Bangaluru.